digital health
Jun 10, 2013
Regulatory concerns shouldn't deter pharma brands from social media: Weber Shandwick
GLOBAL - Internal barriers rather than regulatory concerns are hindering pharmaceutical companies’ ability to build their brands across social media, according to a study conducted by Weber Shandwick and Forbes Insights.
Top news, insights and analysis every weekday
Sign up for Campaign Bulletins
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.jpeg&h=334&w=500&q=100&v=20170226&c=1)
.jpg&h=334&w=500&q=100&v=20170226&c=1)
.png&h=334&w=500&q=100&v=20170226&c=1)
